Structure-Based Design of a Benzodiazepine Scaffold Yields a Potent Allosteric Inhibitor of Hepatitis C NS5B RNA Polymerase

Author:

Vandyck Koen1,Cummings Maxwell D.1,Nyanguile Origène1,Boutton Carlo W.1,Vendeville Sandrine1,McGowan David1,Devogelaere Benoit1,Amssoms Katie1,Last Stefaan1,Rombauts Klara1,Tahri Abdellah1,Lory Pedro1,Hu Lili1,Beauchamp Derek A.2,Simmen Kenny1,Raboisson Pierre1

Affiliation:

1. Tibotec BVBA, Generaal de Wittelaan L 11B 3, B-2800 Mechelen, Belgium

2. Johnson & Johnson Pharmaceutical Research & Development, Raritan, New Jersey 08869

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Reference20 articles.

1. World Health Organization (WHO). Hepatitis C. Fact Sheet No. 164. Revised October 2000.http://www.who.int/mediacentre/factsheets/fs164/en/ (2000) .

2. The way forward in HCV treatment — finding the right path

3. The design of drugs for HIV and HCV

4. 1,5-Benzodiazepines, a Novel Class of Hepatitis C Virus Polymerase Nonnucleoside Inhibitors

5. 1,5-Benzodiazepine inhibitors of HCV NS5B polymerase

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3